Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects by MacLaren, Robin E et al.
RESEARCH ARTICLE Open Access
Association of adipocyte genes with ASP
expression: a microarray analysis of subcutaneous









Background: Prevalence of obesity is increasing to pandemic proportions. However, obese subjects differ in insulin
resistance, adipokine production and co-morbidities. Based on fasting plasma analysis, obese subjects were
grouped as Low Acylation Stimulating protein (ASP) and Triglyceride (TG) (LAT) vs High ASP and TG (HAT).
Subcutaneous (SC) and omental (OM) adipose tissues (n = 21) were analysed by microarray, and biologic pathways
in lipid metabolism and inflammation were specifically examined.
Methods: LAT and HAT groups were matched in age, obesity, insulin, and glucose, and had similar expression of
insulin-related genes (InsR, IRS-1). ASP related genes tended to be increased in the HAT group and were correlated
(factor B, adipsin, complement C3, p < 0.01 each). Differences between LAT and HAT group were almost
exclusively in SC tissue, with little difference in OM tissue. Increased C5L2 (p < 0.01), an ASP receptor, in HAT
suggests a compensatory ASP pathway, associated with increased TG storage.
Results: HAT adipose tissue demonstrated increased lipid related genes for storage (CD36, DGAT1, DGAT2, SCD1,
FASN, and LPL), lipolysis (HSL, CES1, perilipin), fatty acid binding proteins (FABP1, FABP3) and adipocyte
differentiation markers (CEBPa, CEBPb, PPARg). By contrast, oxidation related genes were decreased (AMPK, UCP1,
CPT1, FABP7). HAT subjects had increased anti-inflammatory genes TGFB1, TIMP1, TIMP3, and TIMP4 while
proinflammatory PIG7 and MMP2 were also significantly increased; all genes, p < 0.025.
Conclusion: Taken together, the profile of C5L2 receptor, ASP gene expression and metabolic factors in adipose
tissue from morbidly obese HAT subjects suggests a compensatory response associated with the increased plasma
ASP and TG.
Background
Obesity is a risk factor for metabolic syndrome, cardio-
vascular disease, and diabetes [1,2]. The incidence of
obesity has increased dramatically in the last decade
throughout the world [3]. The rate of deaths from obe-
sity related diseases is also on the rise. Understanding
the factors that contribute to obesity related diseases is
crucial to help obese patients achieve better health
status.
Notwithstanding the strong associations of obesity
with dyslipidemia and insulin resistance, it has been
recognized in recent years that not all forms of obesity
are the same. Visceral obesity presents a greater risk for
obesity related disease than subcutaneous obesity [4].
Classification of obese populations based on their level
of insulin sensitivity identifies distinct subsets variously
referred to as insulin-sensitive obese [5-7], metaboli-
cally-healthy but obese [8], and metabolically-normal
obese [9]. In each of these cases, specific parameters,
such as glucose or insulin, are within the normal healthy
range found in non-obese subjects. Most studies classify
“healthier obese subjects” according to insulin
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as HDL cholesterol, plasma triglycerides [9,10], C-reac-
tive protein, interleukin-6, LDL cholesterol, and visceral
fat [11]. We have recently shown that intracellular insu-
lin signalling pathways in adipose tissue are different
between insulin sensitive versus insulin resistant obese
subjects [12].
However, in addition to altered glucose metabolism,
dyslipidemias, such as elevated plasma triglyceride (TG),
are common in obesity and are an independent risk fac-
tor for many diseases including diabetes, metabolic syn-
drome, and cardiovascular disease [1]. When coupled
with other risk factors such as high LDL cholesterol,
low HDL cholesterol, or insulin resistance, the risk for
these diseases increases [13,14]. Accordingly, in the pre-
sent study, obese subjects were evaluated based on char-
acterization according to fasting triglyceridemia and
acylation stimulating protein (ASP) to examine potential
differences in adipose tissue gene expression.
Cellular studies have demonstrated that acylation sti-
mulating protein (ASP) is a main anabolic stimulator of
TG storage in adipose tissue and is produced by adipo-
cytes [15]. ASP stimulates TG synthesis via the ASP
receptor, C5L2, a seven transmembrane G protein
coupled receptor [16,17]. Downstream several key sig-
nalling proteins have been identified, including phos-
pholipase C, phosphatidylinositol-3 kinase, Akt and
protein kinase C [18] culminating in increased glucose
transport and diacylglycerol acyltransferase activity [18].
ASP is identical to C3adesArg and is produced through
the interaction of the precursor protein C3, Factor B,
and adipsin (a.k.a. Factor D), components of the alterna-
tive complement immune pathway which are secreted
by adipose tissue.
In the adipose tissue milieu ASP levels increase post-
prandially, although general circulating levels change lit-
tle [19-21]. Overall, fasting ASP is strongly predictive of
postprandial TG (evaluated as area-under-the-curve:
AUC) in both men and women [22]. ASP is increased in
obesity, as well as insulin resistance, diabetes, cardiovas-
cular disease, hyperthyroidism and polycystic ovary syn-
drome [15,23-25], all disorders associated with obesity
[26,27]. However obesity is not an essential feature of
elevated ASP levels, as ASP is increased in subjects with
diabetes or polycystic ovary syndrome, even in the
absence of obesity [25].
A direct association between plasma ASP on one hand
and the metabolic function of the subcutaneous and
omental adipose tissue on the other hand are unknown,
and this is the first study to examine this. Further there
are no studies on C5L2 adipose expression in humans.
Our hypothesis was that morbidly obese subjects sepa-
rated based on the fasting plasma levels of ASP and TG
into HAT (High ASP and Triglyceride) and LAT (Low
ASP and Triglyceride) groups would demonstrate differ-
ential expression of genes in lipid metabolic and inflam-
matory biologic pathways. Characterization of
subcutaneous and omental adipose tissue using a micro-
array approach was used. To target lipid metabolic and
inflammatory biologic pathways, all known genes in
these pathways were identified and all those available in
t h em i c r o a r r a yw e r ep o o l e dap r i o r i ,a n dt h e ne x p r e s -
sion in LAT vs HAT for both subcutaneous and omen-
tal adipose tissue was evaluated.
Results
Subject Characteristics
A total of 11 subjects participated in the microarray
study. A fasting blood sample and subcutaneous and
omental adipose tissue samples were taken from each
subject. Of the 21 adipose samples, 20 were paired
omental (OM) and subcutaneous (SC) samples from 10
subjects, and the remaining SC sample was unpaired. As
shown in Table 1, the subjects were divided into 2
groups based on an ASP-TG lipemic index (as described
in methods). Using this functional ASP calculation two
groups were defined, one with low ASP, low TG, and
thus a lower lipemic index which we have termed the
L o wA S Pa n dT Gg r o u p( L A T ,n=4 )a n das e c o n d
group with high ASP (60.5 ± 11.7 vs. 36.1 ± 7.4 nmol/
L), TG (2.01 ± 0.2 vs. 1.3 ± 0.1 mmol/L), and lipemic
index (119.5 ± 22.2 vs. 44.8 ± 5.7, p < 0.05), which we
have termed the High ASP and TG group (HAT, n = 7).
Both groups were morbidly obese based on body mass
index (BMI) where a BMI > 30 kg/m
2 is considered
obese and BMI > 40.0 kg/m
2 is morbidly obese [28].
The two groups did not differ significantly in average
BMI (52.0 ± 5.8 vs. 56.4 ± 4.7, p=ns), nor in average
age. Average insulin and glucose values were the same
between the two groups (Table 1, p ns for all). While
none of the patients had been previously diagnosed as
diabetic, at the time of pre-operative sampling one
Table 1 Subject Characteristics.
Group LAT HAT P
Age 42.2 ± 5.1 42.6 ± 3.6 ns
BMI 52.0 ± 5.8 56.4 ± 4.7 ns
ASP 36.1 ± 7.4 60.5 ± 11.7 0.05
TG 1.29 ± 0.1 2.01 ± 0.2 0.05
Lipemic index 44.8 ± 5.7 119.5 ± 22.2 0.04
Glucose 6.24 ± 1.97 6.22 ± 0.79 ns
Insulin 414 ± 67 384 ± 64 ns
Age (years), body mass index (BMI, kg/m
2), fasting plasma ASP levels (nmol/L),
fasting plasma triglyceride (TG, mmol/L), lipemic index (TG * ASP), fasting
plasma insulin levels (pmol/L) and fasting plasma glucose levels (mmol/L) for
Lower ASP and TG (LAT, n = 4) and Higher ASP and TG (HAT n = 7) subjects.
Data (means ± SEM) are analysed by t test, where p ns indicates not
significant.
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group had glucose values > 7.0. For all tables and fig-
ures, the data are presented as averages ± SEM for the
groups as indicated.
Microarray Analysis
In order to avoid sample bias, no samples were pooled
prior to microarray analysis, and all 21 tissue samples
were analysed individually. Two different analysis para-
digms were used for the evaluation of the microarray
results: (i) overall evaluation using SAM analysis and (ii)
evaluation targeting the specific biological pathways of
interest, lipid metabolism and inflammation. As the pri-
mary hypothesis was to evaluate LAT (Low ASP-TG
index) vs HAT (High ASP-TG index) we first compared
these two groups using overall analysis. The cDNA
microarrays contained a total of ~20,000 probes
(~10,000 human genes, plus ESTs, housekeeping genes,
and positive and negative controls) which were analysed
for all 21 samples. Information on Codelink Uniset 20K
I Gene List #30019 can be obtained directly from http://
www.gehealthcare.com/usen/microarrays/codelink_gene-
lists.html. The complete data set is reported in GEO
(Gene Expression Omnibus) available at: http://www.
ncbi.nlm.nih.gov/geo/ as Accession # GSE 15524.
SAM (Significant Analysis of Microarrays) analysis was
performed on SC and OM samples separately, but using
the same analysis parameters. The SAM procedure [29]
using version 3.09 is available at http://www-stat.stan-
ford.edu/~tibs/SAM using suggested guidelines. This
program is a validated statistical technique for identify-
ing differentially expressed genes across high density
microarrays. With an estimated false discovery rate
(FDR) of 2.0%, and a minimum of a 2-fold change con-
sidered significant, 464 genes were identified as signifi-
cantly different between HAT and LAT in SC tissue
(which represents 2.3% of all genes on the microarray).
Using the same analysis parameters, no genes were iden-
tified as significantly different between HAT and LAT in
OM tissue. Using less stringent criteria (FDR = 5% and
minimum 2-fold change), 1236 genes were identified in
SC, but again, none in OM tissue. Even when criteria
were relaxed to an FDR of 15%, only 6 genes were iden-
tified in OM. Thus, the major changes between HAT
and LAT were restricted to SC adipose tissue. When
gene expression in OM tissue was compared to SC tis-
sue using paired analysis and stringent parameters (FDR
= 2.0% and minimum 2 fold difference), only 108 genes
were identified. Using less stringent criteria (FDR = 5%,
minimum 2 fold change), only 178 significant genes
were identified. By far, the major differences in gene
expression in relation to the classification of subjects as
HAT or LAT using the lipemic index (plasma ASP and
TG) in this sample set are in SC adipose tissue.
Therefore further analysis was focused on SC tissue,
although supplementary information is provided for
omental tissue as well.
The genes identified in SC adipose tissue were further
examined. Of those genes identified as different using
FDR = 2.0% and a minimum twofold change, 453 were
up-regulated (positive genes) and 11 were down-regu-
lated (negative genes) in HAT subjects as compared to
LAT with q values for the genes identified ranging from
0.00000 to 0.02103. Gene description and access to
Codelink Uniset 20K I Gene List #30019 http://www.
gehealthcare.com/usen/microarrays/codelink_genelists.
html were used to assign the genes manually into func-
tional categories. Many of the genes identified (~50%)
were tagged as EST, “hypothetical proteins” or clones
labelled based on putative protein sequence as “similar
to” or “hypothetical” with no known function. Of the
genes with assigned function, the positively regulated
genes coded for proteins involved in extracellular signal-
ling (including cell-cell signalling and endocrine func-
tions), intracellular signalling, intermediary metabolism
and energy metabolism, structural proteins, transcription
and translation (including cell growth, differentiation,
apoptosis and proteolysis) based on manual group
assignment. A supplementary table listing the positive
and negative genes is available upon request.
As the specific aim of the study was to evaluate the
biological pathways of storage lipid metabolism and
inflammation, areas of current interest in adipose tis-
sue biology, a specific analysis was then undertaken of
pathways of interest in SC adipose tissue. First, house-
keeping genes (as controls) were identified, then genes
potentially involved in ASP and C5L2 function were
identified. As ASP represents a crossroad of immune
and lipid metabolism, targeted pathways included all
genes for proteins that could be identified in ASP gen-
eration, complement related factors, storage lipid
metabolism including TG synthesis, lipolysis and oxi-
dation, adipocyte differentiation, and inflammatory
genes. The method of analysis was the following: (i) all
functional genes within the identified biologic path-
ways were listed; (ii) accession numbers were identified
using Entrez Gene http://www.ncbi.nlm.nih.gov/; (iii)
the Codelink gene list was screened to tag all of the
accession numbers present in the array; (iv) all genes
identified, and the associated SC and OM datasets
were then pooled before initiating statistical analysis
and (v) the data was then analyzed for HAT vs LAT.
Using this approach where biologic pathways were
identified a priori followed by subsequent statistical
analysis, of the 88 functional genes identified (exclud-
ing housekeeping genes), 51 were differentially
expressed in relation to HAT vs LAT (Additional File
1, Table S1), either increased or decreased, which
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been identified using the SAM analysis (such as genes
involved in lipid synthesis); this is a substantial path-
way enrichment.
Housekeeping Genes & Insulin Related Genes
The expression of 4 housekeeping genes suggested for
studies in adipose [30] was evaluated across all 11 SC
samples was evaluated (Additional File 2, Table S2). The
expression of B2M, GUSB, PPIA, and TFRC were con-
stant across all 11 samples with no significant differ-
ences when LAT and HAT were compared. There were
no significant correlations between any of the house-
keeping genes and age, BMI, or fasting plasma levels of
ASP, TG, insulin, or glucose.
The expression of insulin receptor (InsR), insulin
receptor substrates 1 and 4 (IRS1 and IRS4), insulin like
growth factors 1 and 2 (IGF1 and IGF2) were also eval-
uated (Additional File 2, Table). The expression of these
genes was also constant across all 11 samples and not
significantly different between the two groups, which is
consistent with the plasma data for insulin and glucose.
There were no significant correlations between these
genes and age or BMI. As the two groups have similar
insulin related gene profiles, differences between the 2
groups are not likely explained by differences in insulin
signalling or sensitivity.
ASP Generation Genes
We next looked at genes related to plasma ASP genera-
tion by adipose tissue. As previously published [31,32],
the key genes in the conversion of complement C3 to
its ASP form (aka C3adesArg) are all produced by adi-
pocytes: C3, factor B (FB), adipsin (or factor D), and
carboxypeptidase N (CPN1). Additionally, factors that
enhance or inhibit the process are also produced by adi-
pocytes: factors H, I, and properdin [33]. As shown in
Figure 1A, C3, factor B and factor H are all moderately
increased in HAT vs LAT (where LAT is set as 100%).
We also analyzed the expression pattern of CR1, aka
CD35, an inhibitor to both the classical and alternative
complement pathways. CR1 inhibits both C3 and C5
convertases, thus decreasing production of C5a, C3a and
desArg forms including ASP, and has a high affinity for
C3b [34]. As CR1 was decreased in HAT SC tissue (Fig-
ure 1A) this reduction may be permissive for increased
ASP production via C3 convertase. Properdin, which
stabilizes C3 convertase, also tended to be increased
(Additional File 1, Table S1). Additionally, C3, adipsin
and factor B were all closely correlated to one another
in SC tissue (Figure 1B to 1D). These 3 genes also cor-
related closely with other genes and have been termed
the “ASP triad” in the present study. In omental (OM)
tissue, although expression of C3 and factor B were
higher than in SC, overall there was no difference
Figure 1 ASP generation related genes tend to be increased in HAT group. (A) Expression of genes related to ASP generation in SC
adipose tissue from LAT (hatched bars) and HAT (solid bars) as assessed by microarray where LAT expression is set at 100%. Correlations are
shown between (B) C3 and factor B (FB), (C) FB and adipsin (Factor D), and (D) C3 and adipsin in SC adipose tissue from both LAT and HAT
subjects. Data is expressed as means ± SEM where * p < 0.025, ** p < 0.01, *** p < 0.001, where R values represent Spearman coefficients, and
lines are based on linear regression.
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a decrease in factor B in HAT subjects (Additional File
1, Table S1).
Real time RT-PCR Analysis of ASP Receptor C5L2
As C5L2, a newly identified receptor, was not present
on the microarray used for analysis, quantitative expres-
sion of C5L2 in the LAT and HAT groups was mea-
sured using TAQMAN real time RT-PCR via the delta-
delta Ct method relative to expression of B2M, a house-
keeping gene. For the real time RT-PCR, a non-obese
control group was added and results are provided for
both SC and OM tissue, as this is the first quantitative
measurement of C5L2 in human adipose tissue. This
additional non-obese group had the following character-
istics: BMI 25.1 ± 1.4 kg/m
2, age 54.8 ± 7.6 years,
plasma ASP 30.4 ± 1.5 nmol/L, plasma TG 1.12 ± 0.18
mmol/L, glucose 3.75 ± 0.21 mmol/L, insulin 137.2 ±
16.1 pmol/L and lipemic index 34.8 ± 6.7. As shown in
Figure 2A, using 2-way ANOVA, there is a significant
difference in groups (p < 0.0001), but no significant dif-
ference between tissues (SC vs OM). With post-hoc
analysis, HAT is significantly increased vs LAT in SC
and OM (p < 0.01 and p < 0.001, respectively), and
HAT is also significantly different from NO in SC and
OM (p < 0.05 and p < 0.001, respectively), while there
was no significant difference between LAT and NO.
There was also a positive correlation between expression
in SC adipose tissue and OM adipose tissue, such that
subjects with high expression in SC tissue also had high
expression in OM (R = 0.676, p = 0.023).
Other complement factors and receptors
The majority of the genes involved in ASP production
were initially identified as being alternative complement
factors and thus part of the immune system [35]. There-
fore we looked at the regulation of other complement
factors, including C5 and two receptors of complement
activation, C3aR and C5aR. The sequence of C5L2 clo-
sely resembles these two receptors. It has been demon-
strated [16,17,36] that C3a, C5a, and ASP all bind to
C5L2, only C3a binds to C3aR, and only C5a binds to
C5aR. Both C3aR and C5aR are expressed at similar
levels in the LAT and HAT groups for both SC and
Figure 2 C5L2 expression is increased in HAT group while similar immune receptors are unaltered. (A) C5L2 gene expression in SC and
OM adipose tissue from control non-obese (NO), LAT, and HAT subjects as assessed by ΔΔ real time RT-PCR for C5L2 relative to the
housekeeping gene B2M. 2-way ANOVA indicates significant differences (p < 0.0001) with a difference between groups (p < 0.0001) but no
significant difference between tissues (pNS). Post-hoc test indicates that HAT was significantly increased vs LAT in SC (p < 0.0.01) and OM (p <
0.001), and HAT was significantly increased vs NO (non-obese) in both SC (p < 0.05) and OM ((p < 0.001) where * p < 0.05, ** p < 0.01 and ***
p < 0.001 for HAT vs LAT and + p < 0.05, ++ p < 0.01 and +++ p < 0.001 for HAT vs NO. There were no significant differences between LAT
and NO. (B) Gene expression of immune receptor genes related to C5L2 in SC adipose tissue from LAT (hatched bars) and HAT (solid bars) as
assessed by microarray where LAT expression is set at 100%. No significant differences between the groups were found for any of the related
receptors. Data is expressed as means ± SEM.
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and there is no significant correlation with C3, factor B
or adipsin, although C5 had a negative correlation.
Lipid Synthesis Genes
A wide variety of genes are involved in dietary lipid sto-
rage and de novo lipid synthesis. We have focused here
on all of the key genes that could be identified from
each pathway including fatty acid and glucose transpor-
ters (CD36, GLUT4), and TG synthesis enzymes such as
diacylglycerol acyltransferases (DGAT1 and DGAT2),
and fatty acid elongating enzymes (ELOV) potentially
related to ASP function. Microarray analysis revealed
increased expression of fatty acid transporter (CD36)
but decreased glucose transporter (GLUT4, Figure 3).
Genes involved in TG synthesis were up-regulated in
the HAT group, including stearoyl CoA desaturase
(SCD1), DGAT1 and DGAT 2, fatty acid synthase
(FASN), phosphatidic acid phosphatase (PAP2A2) and
m a l i ce n z y m e( M E 1 )( F i g u r e3 ,A d d i t i o n a lF i l e1 ,T a b l e
S1). On the other hand, other genes related to de novo
fatty acid synthesis were down-regulated (Figure 3B).
The fatty acid elongation enzyme genes (ELOVL2 and
ELOVL4) were both down-regulated (Figure 3B). By
contrast there were no significant differences in OM tis-
s u e ,o t h e rt h a na ni n c r e a s ei nM E 1i nH A Ts u b j e c t s
(Additional File 1, Table S1). It is interesting to note
that there is a significant correlation with the ASP triad
(C3/B/adipsin) and specific lipid metabolic genes, where
DB1, DGAT1, ME1 and Glut4 are examples (Figure 3
and Additional File 1, Table S1) Several other genes cor-
related well within the group of metabolic genes such as
DGAT1, DGAT2, SCD1, FASN, GLUT4 and ELOV2
(Figure 3 and Additional File 1, Table S1).
Lipolysis Related Genes
A number of intracellular and extracellular adipocyte
lipases hydrolyze TG. The main extracellular lipase,
lipoprotein lipase (LPL), hydrolyzes dietary fats, releas-
ing fatty acids for cellular transport and intracellular
esterification to TG. LPL and hepatic lipase (LIPC), both
of which localize to the cell surface membrane, tended
to be up-regulated in the HAT group vs LAT and corre-
lated significantly with the ASP triad in SC tissue (Fig-
ure 4A, 4C, 4D). On the other hand, two additional
extracellular lipases, pancreatic lipase (PNLIP) and
endothelial lipase (EL), were down-regulated (Figure 4B
and Additional File 1, Table S1).
Hormone sensitive lipase (HSL) was considered the
primary intracellular adipocyte lipase responsible for
releasing fatty acids from the cell; however, additional
lipases have subsequently been identified. Both HSL,
Figure 3 Intracellular lipid synthesis genes in HAT vs LAT in SC adipose tissue. Gene expression of intracellular lipid synthesis genes (A and
B) in SC adipose tissue from LAT (hatched bars) and HAT (solid bars) as assessed by microarray where LAT expression is set at 100%. Correlation
in SC adipose tissue from both LAT and HAT subjects between the ASP triad of genes (C3, factor B and adipsin) and (C) DB1 presented for C3
(open circles), FB (solid circles) and adipsin (stars). R values for C3, FB, and FD respectively are (C) 0.548, 0.639, 0.509. (D) Correlations between
DGAT2 and GLUT4, R = -0.891. Correlations between GLUT4 and DGAT2 and (E) SCD1 and (F) DGAT1 shown as GLUT4 (solid circles) and DGAT2
(stars). R values (Spearman coefficients) for GLUT4 and DGAT2 respectively are (E) -0.952, 0.903 and (F) -0.964, 0.952. Lines are based on linear
regression. Data is expressed as means ± SEM where * p < 0.025, ** p < 0.01 and *** p < 0.001.
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Page 6 of 15Figure 4 Expression of Lipolytic genes in LAT vs HAT. Gene expression of lipolytic genes (A) LPL and LIPC, (B) PNLIP and EL and (E) CES1,
MGLL, HSL, perilipin and (F) adiponutrin in SC adipose tissue from LAT (hatched bars) and HAT (solid bars) as assessed by microarray where LAT
expression is set at 100%. Correlation between the ASP triad of genes and (C) LPL and (D) LIPC are shown for C3 (open circles), FB (solid circles),
and adipsin (stars). R values (Spearman coefficients) for C3, FB, and adipsin respectively are (C) 0.430, 0.600, 0.564 and (D) 0.673, 0.842, 0.709.
Correlations between lipid metabolism genes GLUT4 and DGAT2 with (G) HSL and (H) perilipin are shown for GLUT4 (solid circles) and DGAT2
(stars). R values (Spearman coefficients) for GLUT4 and DGAT2 respectively are (G) -0.952, 0.915 and (H) -0.564, 0.515. Lines are based on linear
regression. Data is expressed as means ± SEM where * p < 0.025, ** p < 0.01 and *** p < 0.001.
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late lipolysis, were up-regulated in the HAT group (Fig-
ure 4E) as were carboxylesterase 1 (CES1, aka
triacylglycerol lipase) and monoglyceride lipase (MGLL)
(Figure 4E). These lipases correlated closely with the
metabolic genes GLUT4, DGAT2 and HSL (Figure 4G,
4H, Additional File 1, Table S1). Adiponutrin, on the
other hand, was down-regulated in the HAT group (Fig-
ure 4F). Again, there were no differences for any of the
genes in OM tissue, other than a decrease in LIPC in
HAT subjects (Additional File 1, Table S1).
Oxidation Genes
A number of genes related to oxidation in adipose tissue
were down-regulated in HAT vs LAT (Additional File 1,
Table S1), including carnitine palmitoyltransferase
(CPT-1C), carnitine acetyltransferase (CRAT), uncou-
pling protein (UCP1), AMP-activated kinase (AMPK) as
well as some AMPK regulatory genes (PRKAB2,
PRKAG3, Additional File 1, Table S1). Other AMPK
regulatory genes (PRKAA1, PRKAG1, and PRKAG2)
were up-regulated in the HAT group (Additional File 1,
Table S1). Acetyl CoA carboxylase (ACC) was increased
in SC HAT tissue, and had some weak correlations with
the ASP triad (Additional File 1, Table S1). The con-
trasting regulation of ACC and AMPK is reflected in
their opposing physiological roles: ACC catalyzes the
rate limiting step in fatty acid synthesis and AMPK
senses energy availability and inactivates ACC. CPT-1C
and UCP1 (Additional File 3, Figure S1) were both cor-
related with GLUT4 and DGAT2 but, consistent with
the trends described above, only partially with any of
the genes from the ASP triad (Additional File 1, Table
S1). There were no differences in OM tissue between
LAT and HAT for any genes except for PRKAG1 which
increased in HAT subjects (Additional File 1, Table S1).
Fatty Acid Binding Protein (FABP) Genes
As shown in Additional File4 ,F i g u r eS 2 ,s o m eo ft h e
FABP group of genes were up-regulated in the HAT SC
tissue, but not all (Additional File 4, Figure S2). Several
correlated strongly with the ASP triad (Additional File
4, Figures S2C to S2E). Although FABP4 was first iden-
tified in adipose tissue [37], all of these binding proteins
are ubiquitously expressed. Further, FABP2 and FABP7
are decreased (Additional File 4, Figure S2B). The roles
of FABP are varied, including differential binding of var-
ious fatty acids, with functional links that include signal-
ling and association with transcription factors,
channelling to lipid synthesis vs oxidation, cell growth,
proliferation and differentiation [38]. These differential
roles of FABP may explain the opposite changes. How-
ever no differences were detected in OM tissue (Addi-
tional File 1, Table S1).
Differentiation Genes: the C/EBP and PPAR families
Both the C/EBP and the PPAR nuclear receptor families
are important factors in adipocyte differentiation. The
C/EBP genes a and b were increased (Figure 5), while
C/EBPε was decreased (Figure 5B). C/EBPb is a check-
point for differentiation and is induced by C/EBPa,
which is increased early in the differentiation process.
Interestingly, C/EBPg correlates with the ASP triad (Fig-
ure 5C).
PPARg is best recognized as a late marker of differen-
tiation. PPARg was increased in the HAT group, along
with many of the other differentiation genes (Figure
5A). However, PPARδ was an exception, being signifi-
cantly down-regulated (Figure 5B). While the role of
PPARδ is not fully understood, it is believed that activa-
tion of PPARδ leads to increased fatty acid metabolism
[39]. In accordance with decreased expression of genes
in fatty acid oxidation, and increased expression of fatty
acid storage genes, the decrease in PPARδ is consistent
with that interpretation. The majority of differentiation
genes correlate with the metabolic genes (Figure 5).
There was no change in OM tissue for any of the genes
examined (Additional File 1, Table S1).
Inflammatory Genes
Recently, there has been intense interest in the potential
interactions between adipocytes and macrophages within
the adipose tissue milieu. The potential role of ASP in
both the immune system and storage lipid metabolism
makes it all the more pertinent to examine pro-and
anti-inflammatory genes in association with ASP and
the lipemic index. The anti-inflammatory genes trans-
forming growth factor beta 1 (TGFB1) and tissue inhibi-
tor of metalloproteinase (TIMP1, 3 and 4) were
increased in the HAT group (Additional File 5, Figure
S3A), with decreases in some interleukin genes such as
IL4. Of the pro-inflammatory interleukin and receptor
genes, there was little difference between the LAT and
HAT groups other than for PIG7 (Additional File 5, Fig-
ure S3B) with no difference in OM tissue (Additional
File 1, Table S1).
Hand in hand with inflammation of adipose tissue, is
remodelling of adipose tissue. Key genes in this process
are macrophage recruitment genes and matrix metallo-
proteinases [40,41]. A number of genes for macrophage
recruitment tended to be increased in the HAT group
in subcutaneous tissue, especially macrophage migration
inhibitory factor (MIF) and chemokine (C-C motif)
receptor 2 (CCR2) genes which were also closely corre-
lated with the ASP triad of genes (Additional File 6, Fig-
ures S4A-S4C). Of the matrix metalloproteinases,
MMP20 and MMP10 were significantly down-regulated
in the HAT group (Additional File 6, Figures S4D) while
MMP 2 was increased. OM tissue had no significant
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Table S1).
Confirmatory Analysis by Real Time PCR
Confirmatory analysis by real time PCR using the delta-
delta Ct method relative to expression of B2M, a house-
keeping gene, was also conducted for 7 additional genes.
The genes chosen included two genes with markedly
increased expression in HAT vs LAT (CD36 and
DGAT2), two genes with moderately increased expres-
sion in HAT vs LAT (C3 and CEBPg)a n dt w og e n e s
with little change in expression in HAT vs LAT (C5aR
and FABP4). In addition, results for insulin receptor
(INSR) were also presented. Further, all genes were ana-
lyzed in both SC and OM tissue, for all samples avail-
able, in duplicate or triplicate. As can be seen in Table
2, overall results from the real-time PCR correlated well
with the results from the microarray analysis in both SC
and OM tissues from LAT and HAT subjects.
Discussion
Adipose tissue has been well documented as an endo-
crine organ in the last two decades [42]. The recognition
that ASP (aka C3adesArg) is produced by adipose tissue,
Figure 5 Expression of CEBPs and PPARs in LAT vs HAT. Gene expression of differentiation related gene families, CEBPs and PPARs (A and B)
in SC adipose tissue from LAT (hatched bars) and HAT (solid bars) as assessed by microarray where LAT expression is set at 100%. Correlations
between the ASP triad and CEBPg are shown in (C) with R values (Spearman coefficients) for C3, FB, and adipsin are 0.527, 0.709, and 0.698
respectively. Correlations for CEBPa (D) and PPARδ (E) with GLUT4 and DGAT2 respectively are (D) -0.915, 0.830 and (E) 0.758, -0.673. Lines are
based on linear regression. Data is expressed as means ± SEM where * p < 0.025, ** p < 0.01 and *** p < 0.001.
Table 2 Real Time PCR Analysis of Selected Genes in Subcutaneous and Omental LAT and HAT Groups
Gene Accession # Subcutaneous Omental
LAT HAT % LAT HAT %
C5L2 NM_018485 0.950 ± 0.105 1.958 ± 0.237** 206% (NA) 1.161 ± 0.096 2.684 ± 0.263** 231% (NA)
C3 NM_000064 0.588 ± 0.086 0.928 ± 0.117* 158% (134%) 2.655 ± 0.829 2.344 ± 0.026 88% (45%)
C5aR NM_00173 1.412 ± 0.189 1.588 ± 0.120 112% (78%) 1.738 ± 0.240 1.926 ± 0.229 111% (122%)
CD36 NM_000072 0.877 ± 0.134 1.717 ± 0.212** 196% (268%) 0.411 ± 0.072 0.874 ± 0.103** 213% (96%)
DGAT2 NM_032564 1.671 ± 0.358 3.383 ± 0.513* 202% (245%) 0.606 ± 0.207 1.110 ± 0.151* 183% (144%)
FABP4 NM_001442 0.732 ± 0.093 0.776 ± 0.075 106% (128%) 0.638 ± 0.064 0.739 ± 0.083 116% (92%)
CEBPg NM_001806 1.006 ± 0.226 1.497 ± 0.126* 160% (143%) 3.371 ± 1.694 3.607 ± 1.318 97% (75%)
INSR X02160 1.553 ± 0.278 1.580 ± 0.252 102% (112%) 1.407 ± 0.617 1.630 ± 0.371 116% (62%)
Gene expression in SC and OM adipose tissue from Lower ASP and TG (LAT) and Higher ASP and TG (HAT) subjects as assessed by ΔΔ real time RT-PCR relative
to the housekeeping gene B2M. Data are means ± SEM (n = 8 to 16 total per group) and are analysed by t test, where * p < 0.05, and ** p < 0.01. Percentage
change of HAT vs LAT is provided, with the comparative value from microarray analysis (see Figures and Additional File 1, Table S1 for data) given in
parentheses, where NA = not available.
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adipsin, all increase with differentiation of adipocytes
[43] was one of the first demonstrations that hormones
with both paracrine and endocrine functions were pro-
duced within the adipose milieu. The primary function
of ASP in adipocytes appears to be promotion of lipid
storage, and this is achieved through increases in fatty
acid esterification and glucose uptake [44].
A number of human studies have demonstrated posi-
tive associations between ASP and various metabolic
disturbances (diabetes, metabolic syndrome, cardiovas-
cular disease, nephrotic syndrome, polycystic ovary syn-
drome) with or without the presence of obesity.
Previous studies have demonstrated that circulating
plasma ASP is associated with TG and fatty acid levels
[15], with a strong correlation between fasting ASP and
postprandial TG clearance even in non-obese individuals
[22]. The demonstration of direct adipose tissue produc-
tion of ASP postprandially in human studies [19-21],
coupled to evidence that dietary TG in the form of chy-
lomicrons directly stimulate C3 and ASP production in
cultured human adipocytes [45,46] provides a strong
link between plasma ASP and TG. Consequently, the
aim of the present study was to evaluate microarray
expression in subcutaneous vs. omental adipose tissue in
relation to plasma ASP and TG (lipemic index), and
genes directly related to ASP production, storage lipid
metabolism and inflammation.
However, there are several limitations to this study.
The samples were derived from morbidly obese subjects,
limiting interpretations to that population. Further,
although there were often large relative differences
between the two groups (LAT vs HAT), the limited
number of samples restricted the statistical power.
There was also no functional analysis of the adipose tis-
sue. On the other hand, the strengths of the study are
that no samples were pooled and microarray analysis
was conducted individually on all 21 samples. It should
be noted that intact adipose tissue was specifically cho-
sen for the analysis. This tissue represents a pool of adi-
pocytes as well as preadipocytes, macrophages, and
endothelial cells. Direct analysis of the tissue prevented
the introduction of artefactual changes resulting from
processing and separating the various cell populations.
Hence, this can be viewed as both a strength and a
weakness.
Interestingly, while the design of the study allowed for
a comprehensive comparison of gene expression
between SC and OM adipose tissue, we discovered that
the significant differences were found primarily in the
SC tissue. SAM analysis determined that OM tissue did
not have significant differences between the LAT and
HAT groups. Targeted analysis of specific biological
pathways allowed us to compare genes from many
different gene families simultaneously. Differential
results between LAT and HAT in the SC tissue included
genes involved in the alternative complement system,
lipid synthesis, lipolysis, oxidation, fatty acid binding
proteins, markers of differentiation, pro-inflammatory,
anti-inflammatory, macrophage recruitment, and matrix
remodelling genes. This contrasts markedly with a pre-
vious study comparing insulin resistant obese with insu-
lin sensitive obese where differences were primarily
noted in OM tissue, with no differences in SC tissue
[12]. This is a particularly interesting point. While dif-
ferences in omental adipose tissue in relationship to
insulin resistance have been noted (in microarray studies
and others), our present study specifically identified dif-
ferences in subcutaneous adi p o s et i s s u ew i t hr e s p e c tt o
ASP related metabolism. While differences in subcuta-
neous adipose tissue have been identified using other
biochemical parameters (such as differences in triglycer-
ide synthesis in subcutaneous adipose tissue in non-
obese vs obese subjects) this is the first to identify this
based on ASP metabolism. We speculate (as a hypoth-
esis to be tested) that this may indicate a compensatory
mechanism, whereby genes related to ASP are concomi-
tantly increased with genes related to lipid storage, how-
ever this remains to be tested in future studies.
In contrast to the demonstrated changes in the gene
families described above, there were no significant dif-
ferences in housekeeping genes, insulin signalling genes
and non-related complement genes between these two
groups (LAT vs HAT). We demonstrated that four
genes commonly reported as housekeeping genes [30],
B2M, GUSB, PPIA, and TFRC, were not significantly
different between the LAT and HAT groups nor did
they correlate with age or BMI. Further, not only were
plasma glucose and insulin comparable between the 2
groups, the expression of genes related to insulin resis-
tance and insulin signalling such as insulin receptor
InsR, IRS-1, IRS-4, IGF1, and IGF2 were comparably
expressed between LAT and HAT groups, and did not
correlate with age or BMI. Further, the expression of
other complement genes (C5) and receptors (C3aR,
C 5 a R )t h a ta r en o ti n v o l v e di nA S Pp r o d u c t i o no rs i g -
nalling were not different between groups (LAT and
HAT). This suggests that there is selective regulation of
metabolic genes directly related to the role of ASP, inde-
pendent of insulin or other immune related genes.
On the other hand, there was a strong association
between increased plasma ASP and TG (lipemic index)
and expression of the genes related directly to ASP pro-
duction and function. Thus complement C3, factor B
and adipsin were generally increased in the microarray
in HAT vs LAT groups. Further, C5L2, the receptor for
ASP, was assessed by real-time PCR, and expression was
also increased in HAT vs LAT. C5L2, a G protein
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human adipocytes and preadipocytes [17], but this is the
first quantitative evaluation of C5L2 reported in human
adipose tissue. While C5L2 is increased in the HAT
group, the expression of C5L2 in the LAT group is very
similar to the non-obese control group in both SC and
OM tissue. Further, in the present study there was a sig-
nificant correlation between C5L2 expression in SC and
OM adipose tissue. These results are consistent with
increased binding of ASP to adipose plasma membranes
in obese subjects vs non-obese subjects, although the
C5L2 receptor was as yet unrecognized at that time, and
no plasma data was available [47]. We have also pre-
viously demonstrated an association between SC and
OM adipose tissue for radiolabelled ASP binding to
plasma membranes, across a range of BMI from obese
and non-obese subjects. On the other hand, in our pre-
vious study, ASP binding and affinity was greater in SC
vs OM adipose tissue, while in the present study, C5L2
mRNA expression was not different in SC vs OM,
which could reflect a further level of regulation at the
plasma membrane.
This is the first study evaluating expression of ASP
related genes, including the receptor C5L2, in the con-
text of plasma ASP. The few studies that have examined
complement C3 gene expression in adipose tissue have
demonstrated associations with BMI, adipose tissue site,
insulin sensitivity, age and postprandial lipemia [48-53].
Only one study examined the levels of plasma ASP in
relationship to adipose tissue gene expression and
demonstrated significant associations between C3
mRNA, plasma ASP and both insulin sensitivity and
postprandial TG [51].
This raises the question whether chronically increased
plasma ASP represents an ASP resistant state (analogous
to increased plasma insulin reflecting insulin resistance),
or whether the increased ASP is compensatory.
Hypothetically, the presence of increased plasma ASP,
increased expression of C3, factor B and adipsin in the
microarray and increased C5L2 based on real-time PCR
would suggest a compensatory mechanism, indicative of
a more effective response, and interpretation of the
results are evaluated in that context below.
T h e r ew a sas t r i k i n gc o r r e lation between the three
genes most relevant to ASP production: C3, Factor B,
and adipsin (aka Factor D), constituting an ASP triad.
Other complement genes (C3aR and C5aR) that are
neither related to ASP production nor signalling do not
correlate with the “ASP triad.” This selectivity within
the alternative complement pathway and the correlation
with many metabolic genes points to the physiological
relevance. A general trend observed was that the HAT
group has up-regulated genes for lipid TG storage.
Along with the high plasma ASP and high C5L2
receptor, there are multiple genes including intracellular
lipid storage, lipoprotein lipase, and fatty acid trafficking
genes that are increased in the HAT group. The simul-
taneous increase in both lipid storage and lipolytic genes
suggests an overall increase in substrate cycling and
fatty acid flux [2,54]. Concurrently, de novo TG synth-
esis and oxidative genes were down-regulated. Taken
together, the cells appear to be responding to an
increased plasma TG level in the HAT group and are
increasing their uptake and storage of TG. Many of the
increased storage genes correlated with the “ASP triad”
of genes including DB1 and LPL. Among the oxidative
genes, ACC correlates negatively with the ASP triad.
Changes in adipose tissue function implicate altera-
tions in differentiation genes, remodelling genes, and
inflammatory complications [40,41,55,56]. The HAT
group is characterized by increased in differentiation
factors CEBPa, b, and CEBPδ as well as PPAR g, consis-
tent with the increased TG storage genes. Interestingly,
we have previously demonstrated that ASP stimulates
adipogenesis in cultured 3T3-L1 and 3T3-F442A cells,
reflected by early increases in CEBP, followed later by
increases in PPARg, DGAT-1, adipsin and TG accumu-
lation [57].
The HAT group is also characterized by increased
anti-inflammatory gene TGFb1 and inhibitors of metal-
loproteinases TIMP1, TIMP3 and TIMP4 and decreased
metalloproteinase MMP20 and MMP10. On the other
hand, there were few increases in pro-inflammatory
genes, although pro-inflammatory and cell remodelling
factors such as PIG7, CCR2 and MMP2 were increased.
An interesting link between the role of the alternative
complement pathway factors ASP and C5L2 and
immune and adipose have been supported by active
demonstration of adipose tissue macrophage infiltration,
apoptosis and tissue remodelling in obesity, and the dif-
ferences demonstrated between HAT and LAT.
Conclusion
Overall, the profile of C5L2 receptor, ASP gene expres-
sion and metabolic factors in adipose tissue from the
HAT group of morbidly obese subjects suggests a com-
pensatory response associated with the increased plasma
ASP and TG. A shift in the various pro-inflammatory,
anti-inflammatory, macrophage recruitment and matrix
remodelling proteins demonstrates a differential expres-
sion in the HAT group, although the specific benefits or




Men and women living in Montreal, Canada were
recruited for this study. Altogether, for the microarray
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obese (BMI > 40 kg/m
2). Chi
2 analysis indicated no sig-
nificant difference in gender distribution. A sample of
subcutaneous and omental adipose tissue along with a
fasting blood sample were collected during gastric
bypass surgery (n = 11). Ethics approval for this project
was obtained from the McGill University Health Centre
(Royal Victoria Hospital) ethics review committee (Mon-
treal, QC) and subjects signed an informed consent
form prior to participation. Of the 11 subjects, none had
previously been identified as having diabetes or any
other known disease (other than the presence of morbid
obesity). All women were pre-menopausal. None were
taking hypoglycaemic or lipid lowering medication. Body
weight was stable at the time of study.
For the real time RT-PCR analysis, a lean control
group was included to compare C5L2 gene expression
(a gene not on the microarray) to the morbidly obese
subjects. This group consisted of four non-obese sub-
jects, two women and two men. Adipose tissue samples
were collected during elective hysterectomy surgery (n =
2), valve replacement (n = 1), and hernia (n = 1) sur-
geries. All other inclusion/exclusion parameters were
the same as for the morbidly obese group. Although we
c a n n o tr u l eo u tt h ep r e s e n c eo fa ni n f l a m m a t o r yc o m -
ponent in these subjects, all were elective and not emer-
gency surgeries.
Blood samples
Venous blood samples were collected in the fasting state
into non-heparinized EDTA tubes. Samples were col-
lected at 7:00 am, on the ward following a 12 hour fast,
prior to transfer of patients to surgery. Blood samples
were centrifuged at 2000 rpm at 4°C for 10 minutes and
plasma was stored at -80°C for later analysis. Insulin
levels were measured by RIA (Medicorp, Montreal,
Canada). Glucose was measured by colorimetric enzyme
assay (GOD-PAP, Roche Diagnostics. Plasma triglycer-
ides were measured by GPO-PAP (glycerol phosphate
oxidase coupled to phenol and 4-aminophenazone)
method. ASP levels were measured by colorimetric
enzymatic ELISA [44].
Calculation of Indices
A lipemic index utilizing the fasting values of ASP and
TG was calculated. ASP strongly correlates with post-
prandial TG [22], therefore a lipemic index of [ASP ×
TG] may be indicative of ASP effects on clearance of
postprandial TG.
Adipose tissue microarray
Adipose tissue was collected at the beginning of the
operation (within 30 minutes) into sterile 50 mL conical
tubes and immediately flash- frozen in liquid nitrogen.
Subcutaneous adipose tissue was collected from the sub-
cutaneous abdominal wall and omental adipose tissue
was collected from the greater omentum which is repre-
sentative of intra-abdominal adipose depots drained by
the portal vein. RNA was extracted from tissues using
Qiagen spin columns (Qiagen, Mississauga, Canada) fol-
lowing manufacturer’s protocol for fatty tissue with the
addition of two RNase free DNase treatments (Qiagen)
between RW1 washes. RNA quality was assessed by
spectrometry (260/280 ratio) with ratios of 1.9 - 2.0. As
well, RNA quality was assessed by chromatography.
Synthesis of cRNA by in vitro transcription and hybridi-
sation was performed as previously described [12,58].
Briefly, 10 ug of high quality total RNA was converted
to cDNA and then to biotin-labelled cRNA (10 mM
Biotin-11-UTP, Perkin-Elmer) by linear amplification
(iExpress Assay reagent kit, GE Healthcare Bio-Sciences,
Montreal, Quebec). 10 ug of labelled cRNA was hybri-
dised to CodeLink UniSet Human 20 K I (GE Health-
care Bio-Sciences). The microarray slides were
processed according to manufacturer’si n s t r u c t i o n sa n d
analysed using Codelink System Software (GE Health-
care Bio-Sciences). The spot intensities were median
normalized (signal intensity of probe/median intensity of
all discovery probes). The results have been deposited to
GEO database under accession number GSE 15524.
Real Time RT-PCR
Real time RT-PCR was used to evaluate the expression
pattern of C5L2, the ASP receptor, because no probes
for C5L2 were present on the microarray. The specific
primer/probe sets used were human C5L2
(Hs_00218495). Confirmatory RT-PCR was also ana-
lyzed for 7 additional genes (complement C3 (C3), C5a
receptor (C5aR), CD36, diacylglycerol acyltransferase 2
(DGAT2), fatty acid binding protein 4 (FABP4), CEBPg
and insulin receptor (INSR), as well as a housekeeping
gene beta-2-microglobulin (B2M, 4326319E). All primer-
éprobe sets were obtained from Applied Biosystems
(Toronto, Canada). RNA was collected as described
above for the real time RT-PCR and run separately from
the microarray. RNA (2 ug) was reverse transcribed to
cDNA using the High Capacity cDNA RT kit (Applied
Biosystems) according to manufacturer’sp r o t o c o l s .A l l
primer/probe sets were validated over an exponential
range of 1:2 to 1:7500 dilutions of cDNA concentrations.
A positive control consisting of pooled adipose tissue
RNA isolated from human adipose tissue was used to
establish the dynamic range of the assay for each pri-
mer/probe specifically in adipose tissue. Detection of the
fluorescent signal was quantified by Rotor-Gene 3000
(Corbett Research). The control sample was assayed in
each real-time PCR run to ensure consistency. For all
s a m p l e s ,ad i l u t i o no f1 : 5 0o ft h ec D N Aw a su s e d ,
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and all samples (n = 15) were analysed simultaneously,
in duplicate or triplicate (no samples were pooled).
Expression patterns for all genes, including C5L2 were
analysed by real-time PCR using delta delta CT method
expressed relative to the housekeeping gene B2M,
according to manufacturer’s protocol. Further, B2M was
shown to be consistent across all samples (no significant
changes) in both the microarray analysis (Additional File
2, Table S2) and in real time RT-PCR.
Analysis and Statistics
Plasma data is presented as means ± SEM, and the two
groups (HAT vs LAT) were compared by 2-sided t-test.
The results were considered significant with p-values ≤
0 . 0 5 .F o rr e a l - t i m eP C R ,d a t ai sp r e s e n t e da sm e a n s±
SEM data. For C5L2 data, the groups were compared by
t w o - w a yA N O V Af o rt i s s u e( S Ca n dO M )a n dg r o u p s
(HAT, LAT, and NO) with all-pairwise post-hoc test used
to compare significant differences between groups. For all
other genes analyzed by real-time PCR, the two groups
(HAT vs LAT) were compared by 2-sided t-test. The
results were considered significant with p-values ≤ 0.05.
Two types of analysis were conducted for the microar-
ray analysis: (i) SAM analysis and (ii) targeted analysis of
biologic pathways involved in lipid storage and inflam-
mation. For the former, analysis was conducted using
SAM (Significant Analysis of Microarrays) program [29]
version 3.09 and available at http://www-stat.stanford.
edu/~tibs/SAM using suggested guidelines (see on-site
manual). This program is a validated statistical techni-
que for identifying differentially expressed genes across
high density microarrays. This analysis technique pro-
vides a list of significant differentially expressed genes
and their q values, and an estimate of the false discovery
rate (FDR) which represents the percentage of genes
that could be identified by chance [29]. Following SAM
analysis of subcutaneous and omental tissues, we further
analyzed the data targeting specific metabolic biologic
pathways (according to the a priori hypothesis).
F o rt h et a r g e t e dm i c r o a r r a ya n a l y s i s ,t h ef o l l o w i n g
procedure was used: (i) using known biochemical path-
ways, a list of proteins/genes involved in ASP genera-
tion, complement related factors, lipid storage
metabolism including TG synthesis, lipolysis and oxida-
tion, adipocyte differentiation, and inflammatory genes
were collated; (ii) accession numbers were identified
using Entrez Gene http://www.ncbi.nlm.nih.gov/; (iii)
the Codelink gene list was screened to tag all of the
accession numbers present in the array; (iv) all genes
identified with the associated SC and OM datasets were
then pooled and (v) the data was then statistically ana-
lyzed for HAT vs LAT. All data was assembled prior to
initiating analysis on HAT vs LAT. All genes identified
in these pathways are presented for SC and OM tissues
(Additional File 1, Table S1), whether significantly dif-
ferent or not (according to a 2-sided t-test).
Microarray data were expressed using mean ± SEM.
The cross-nested design was to analyze two experimen-
tal factors: (i) the comparison between two groups (LAT
versus HAT), and (ii) between the different tissues (SC
vs OM). A mixed model analysis was performed with
interaction between the fixed factors. To proceed with
the analysis, we used a model with a compound symme-
try structure. For most variables, values were log trans-
formed to stabilize variances. Reported p values are
based on these transformations. Relationships between
variables were expressed using Spearman correlation
coefficients. For all microarray data, the results were
considered significant with p-values ≤ 0.025, where ns
indicates not significant. Graphical and statistical ana-
lyses were conducted using GraphPad Prism (San Diego,
CA), SAS, version 9.1.3 (SAS Institute Inc, Cary, NC)
and SigmaStat (Jandel Scientific, CA).
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Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-3-
S4.PDF]
Additional file 5: Figure 3: Inflammatory profile of pro- and anti-
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metalloproteinase genes in SC tissue in HAT and LAT. Graphics
figure of correlations between macrophage recruitment and matrix
metalloproteinase genes
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-8794-3-3-
S6.PDF]
MacLaren et al. BMC Medical Genomics 2010, 3:3
http://www.biomedcentral.com/1755-8794/3/3
Page 13 of 15Acknowledgements
This work was supported by a grant from CIHR (MOP77532) to KC, KC holds
a Canada Research Chair in Adipose Tissue, and RM was supported by a
scholarship from NSERC.
Author details
1Centre de Recherche Institut Universitaire de Cardiologie et de
Pneumologie de Quebec, Laval University, Quebec, G1V 4G5, Canada.
2Experimental Medicine, McGill University Health Centre, Montreal, Quebec,
H3A 1A1, Canada.
Authors’ contributions
RM designed the overall project, recruited samples, carried out the
microarray analysis and real-time PCR analysis as well as analyzed the data
and drafted the manuscript. WC and HLL were responsible for microarray
analysis and real-time PCR (with RM), as well as contributing to data analysis
and writing of the manuscript. SS, a biostatistician, was responsible for
statistical analysis, interpretation and contribution to writing the manuscript.
KC designed and oversaw the research as principal investigator and
contributed to writing the manuscript. All authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 October 2008
Accepted: 27 January 2010 Published: 27 January 2010
References
1. Redinger RN: The prevalence and etiology of nongenetic obesity and
associated disorders. South Med J 2008, 101:395-399.
2. Frayn KN: Adipose tissue and the insulin resistance syndrome. Proc Nutr
Soc 2001, 60:375-380.
3. James WP: The epidemiology of obesity: the size of the problem. J Intern
Med 2008, 263:336-352.
4. Seidell JC, Hautvast JG, Deurenberg P: Overweight: fat distribution and
health risks. Epidemiological observations. A review. Infusionstherapie
1989, 16:276-281.
5. Reaven G: All obese individuals are not created equal: insulin resistance
is the major determinant of cardiovascular disease in overweight/obese
individuals. Diab Vasc Dis Res 2005, 2:105-112.
6. Reaven G, Abbasi F, McLaughlin T: Obesity, insulin resistance, and
cardiovascular disease. Recent Prog Horm Res 2004, 59:207-223.
7. Sims EA: Are there persons who are obese, but metabolically healthy?.
Metabolism 2001, 50:1499-1504.
8. Karelis AD, St Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET: Metabolic
and body composition factors in subgroups of obesity: what do we
know?. J Clin Endocrinol Metab 2004, 89:2569-2575.
9. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA,
Poehlman ET: What are the physical characteristics associated with a
normal metabolic profile despite a high level of obesity in
postmenopausal women?. J Clin Endocrinol Metab 2001, 86:1020-1025.
10. Lim SC, Tan BY, Chew SK, Tan CE: The relationship between insulin
resistance and cardiovascular risk factors in overweight/obese non-
diabetic Asian adults: the 1992 Singapore National Health Survey. Int J
Obes Relat Metab Disord 2002, 26:1511-1516.
11. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH: Weight loss effect on
inflammation and LDL oxidation in metabolically healthy but obese
(MHO) individuals: low inflammation and LDL oxidation in MHO women.
Int J Obes (Lond) 2006, 30:1529-1534.
12. MacLaren R, Cui W, Simard S, Cianflone K: Influence of obesity and insulin
sensitivity on insulin signaling genes in human omental and
subcutaneous adipose tissue. J Lipid Res 2008, 49:308-323.
13. Calabro P, Yeh ET: Intra-abdominal adiposity, inflammation, and
cardiovascular risk: new insight into global cardiometabolic risk. Curr
Hypertens Rep 2008, 10:32-38.
14. Bonora E: The metabolic syndrome and cardiovascular disease. Ann Med
2006, 38:64-80.
15. Cianflone K, Xia Z, Chen LY: Critical review of acylation-stimulating
protein physiology in humans and rodents. Biochim Biophys Acta 2003,
1609:127-143.
16. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN: The
chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/
acylation-stimulating protein. J Biol Chem 2003, 278:11123-11129.
17. Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K:
C5L2 is a functional receptor for acylation-stimulating protein. J Biol
Chem 2005, 280:23936-23944.
18. Maslowska M, Legakis H, Assadi F, Cianflone K: Targeting the signaling
pathway of acylation stimulating protein. J Lipid Res 2006, 47:643-652.
19. Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD:
Increased postprandial fatty acid trapping in subcutaneous adipose
tissue in obese women. J Lipid Res 2000, 41:1963-1968.
20. Saleh J, Summers LK, Cianflone K, Fielding BA, Sniderman AD, Frayn KN:
Coordinated release of acylation stimulating protein (ASP) and
triacylglycerol clearance by human adipose tissue in vivo in the
postprandial period. J Lipid Res 1998, 39:884-891.
21. Sniderman AD, Cianflone K, Summers L, Fielding B, Frayn K: The acylation-
stimulating protein pathway and regulation of postprandial metabolism.
Proc Nutr Soc 1997, 56:703-712.
22. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman A:
Fasting acylation-stimulating protein is predictive of postprandial
triglyceride clearance. J Lipid Res 2004, 45:124-131.
23. Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D,
Cianflone K: Plasma acylation stimulating protein, adipsin and lipids in
non-obese and obese populations. Eur J Clin Invest 1999, 29:679-686.
24. Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, Cianflone K: Thyroid
status influence on adiponectin, acylation stimulating protein (ASP) and
complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab
(Lond) 2006, 3:13.
25. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K:
Relationships among acylation stimulating protein, adiponectin and
complement C3 in lean vs obese type 2 diabetes. Int J Obes (Lond) 2006,
30:439-446.
26. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE,
Schauer PR: The chronic inflammatory hypothesis for the morbidity
associated with morbid obesity: implications and effects of weight loss.
Obes Surg 2004, 14:589-600.
27. Fruhbeck G: The adipose tissue as a source of vasoactive factors. Curr
Med Chem Cardiovasc Hematol Agents 2004, 2:197-208.
28. Sucharda P: [Clinical significance of the quantification of obesity. The
Quetelet index and its use]. Cas Lek Cesk 1989, 128:1040-1043.
29. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001,
98:5116-5121.
30. Gorzelniak K, Janke J, Engeli S, Sharma AM: Validation of endogenous
controls for gene expression studies in human adipocytes and
preadipocytes. Horm Metab Res 2001, 33:625-627.
31. Cianflone KM, Sniderman AD, Walsh MJ, Vu HT, Gagnon J, Rodriguez MA:
Purification and characterization of acylation stimulating protein. J Biol
Chem 1989, 264:426-430.
32. Sniderman AD, Cianflone K: The adipsin-ASP pathway and regulation of
adipocyte function. Ann Med 1994, 26:388-393.
33. Peake PW, O’Grady S, Pussell BA, Charlesworth JA: Detection and
quantification of the control proteins of the alternative pathway of
complement in 3T3-L1 adipocytes. Eur J Clin Invest 1997, 27:922-927.
34. Krych-Goldberg M, Atkinson JP: Structure-function relationships of
complement receptor type 1. Immunol Rev 2001, 180:112-122.
35. Giclas PC: Alternative pathway evaluation. Curr Protoc Immunol 2001,
Chapter 13, Unit.
36. Gerard NP, Lu B, Liu P, Craig S, Fujiwara Y, Okinaga S, Gerard C: An anti-
inflammatory function for the complement anaphylatoxin C5a-binding
protein, C5L2. J Biol Chem 2005, 280:39677-39680.
37. Gerbens F, Jansen A, van Erp AJ, Harders F, Meuwissen TH, Rettenberger G,
Veerkamp JH, te Pas MF: The adipocyte fatty acid-binding protein locus:
characterization and association with intramuscular fat content in pigs.
Mamm Genome 1998, 9:1022-1026.
38. Chmurzynska A: The multigene family of fatty acid-binding proteins
(FABPs): function, structure and polymorphism. J Appl Genet 2006,
47:39-48.
39. Takahashi S, Tanaka T, Kodama T, Sakai J: Peroxisome proliferator-activated
receptor delta (PPARdelta), a novel target site for drug discovery in
metabolic syndrome. Pharmacol Res 2006, 53:501-507.
MacLaren et al. BMC Medical Genomics 2010, 3:3
http://www.biomedcentral.com/1755-8794/3/3
Page 14 of 1540. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M,
Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, et al: Remodeling
phenotype of human subcutaneous adipose tissue macrophages.
Circulation 2008, 117:806-815.
41. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW, DeFuria J, Jick Z,
Greenberg AS, Obin MS: Adipocyte death, adipose tissue remodeling, and
obesity complications. Diabetes 2007, 56:2910-2918.
42. Rocha VZ, Libby P: The multiple facets of the fat tissue. Thyroid 2008,
18:175-183.
43. Cianflone K, Roncari DA, Maslowska M, Baldo A, Forden J, Sniderman AD:
Adipsin/acylation stimulating protein system in human adipocytes:
regulation of triacylglycerol synthesis. Biochemistry 1994, 33:9489-9495.
44. Baldo A, Sniderman AD, St Luce S, Avramoglu RK, Maslowska M, Hoang B,
Monge JC, Bell A, Mulay S, Cianflone K: The adipsin-acylation stimulating
protein system and regulation of intracellular triglyceride synthesis. J
Clin Invest 1993, 92:1543-1547.
45. Maslowska M, Scantlebury T, Germinario R, Cianflone K: Acute in vitro
production of acylation stimulating protein in differentiated human
adipocytes. J Lipid Res 1997, 38:1-11.
46. Scantlebury T, Maslowska M, Cianflone K: Chylomicron-specific
enhancement of acylation stimulating protein and precursor protein C3
production in differentiated human adipocytes. J Biol Chem 1998,
273:20903-20909.
47. Saleh J, Christou N, Cianflone K: Regional specificity of ASP binding in
human adipose tissue. Am J Physiol 1999, 276:E815-E821.
48. Xia Z, Cianflone K: Acylation-stimulating protein precursor proteins in
adipose tissue in human obesity. Metabolism 2003, 52:1360-1366.
49. Gabrielsson BG, Johansson JM, Lonn M, Jernas M, Olbers T, Peltonen M,
Larsson I, Lonn L, Sjostrom L, Carlsson B, et al: High expression of
complement components in omental adipose tissue in obese men. Obes
Res 2003, 11:699-708.
50. Ylitalo K, Nuotio I, Viikari J, Auwerx J, Vidal H, Taskinen MR: C3, hormone-
sensitive lipase, and peroxisome proliferator-activated receptor gamma
expression in adipose tissue of familial combined hyperlipidemia
patients. Metabolism 2002, 51:664-670.
51. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA,
Ebeling P: Plasma acylation stimulating protein concentration and
subcutaneous adipose tissue C3 mRNA expression in nondiabetic and
type 2 diabetic men. Arterioscler Thromb Vasc Biol 2001, 21:1034-1039.
52. Imbeault P, Vidal H, Tremblay A, Vega N, Nadeau A, Despres JP, Mauriege P:
Age-related differences in messenger ribonucleic acid expression of key
proteins involved in adipose cell differentiation and metabolism. J Clin
Endocrinol Metab 2001, 86:828-833.
53. Dusserre E, Moulin P, Vidal H: Differences in mRNA expression of the
proteins secreted by the adipocytes in human subcutaneous and
visceral adipose tissues. Biochim Biophys Acta 2000, 1500:88-96.
54. Hammond VA, Johnston DG: Substrate cycling between triglyceride and
fatty acid in human adipocytes. Metabolism 1987, 36:308-313.
55. Medina-Gomez G, Gray S, Vidal-Puig A: Adipogenesis and lipotoxicity: role
of peroxisome proliferator-activated receptor gamma (PPARgamma) and
PPARgammacoactivator-1 (PGC1). Public Health Nutr 2007, 10:1132-1137.
56. Poulain-Godefroy O, Lecoeur C, Pattou F, Fruhbeck G, Froguel P:
Inflammation is associated with a decrease of lipogenic factors in
omental fat in women. Am J Physiol Regul Integr Comp Physiol 2008, 295:
R1-7.
57. Maslowska M, Wang HW, Cianflone K: Novel roles for acylation stimulating
protein/C3adesArg: a review of recent in vitro and in vivo evidence.
Vitam Horm 2005, 70:309-332.
58. Jones KL, Kins SS, Iqbal MJ: Endophyte-Infected Tall Fescue Diet Alters
Gene Expression in Heifer Luteal Tissue as Revealed by Interspecies
Microarray Analysis. Molecular Reproductive Developement 2004, , 67:
154-161.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1755-8794/3/3/prepub
doi:10.1186/1755-8794-3-3
Cite this article as: MacLaren et al.: Association of adipocyte genes with
ASP expression: a microarray analysis of subcutaneous and omental
adipose tissue in morbidly obese subjects. BMC Medical Genomics 2010
3:3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
MacLaren et al. BMC Medical Genomics 2010, 3:3
http://www.biomedcentral.com/1755-8794/3/3
Page 15 of 15